51 Biggest Movers From Yesterday

Gainers

  • Sierra Oncology, Inc. SRRA shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients who are symptomatic, anemic, and previously treated with an FDA-approved JAK inhibitor. The company also entered into a term loan agreement with Oxford Finance LLC to support the commercial preparation and potential launch of momelotinib.
  • Aptorum Group Limited APM shares gained 38.9% to close at $22.68 after gaining around 10% on Monday. The FDA recently granted Orphan Drug Designation to Aptorum Group’s SACT-1, a repurposed small molecule compound for Neuroblastoma.
  • Exela Technologies, Inc. XELA jumped 33% to settle at $0.55 after the company announced a renewal of its services contract with a consulting firm. The total contract value is over $35 million.
  • Vistas Media Acquisition Company Inc. VMAC gained 27.3% to close at $13.90. Vistas Media Acquisition Company shareholders recently approved a business combination with Anghami.
  • Aditxt, Inc. ADTX gained 25.7% to close at $0.4549. Aditxt recently reported submission of 2 requests for emergency use authorization to the FDA for AditxtScore for covid-19 tests to measure quantity and quality of antibodies against covid and variants including omicron.
  • Mind Medicine (MindMed) Inc. MNMD jumped 25.5% to close at $1.17 after the company announced the FDA cleared its Investigational New Drug application, allowing its Phase 2b dose-optimization trial of MM-120 for the treatment of generalized anxiety disorder to proceed.
  • SmileDirectClub, Inc. SDC gained 24.6% to close at $2.48 after the company announced strategic actions to increase profitability.
  • ClearOne, Inc. CLRO jumped 23.5% to settle at $1.07.
  • Bally's Corporation BALY rose 22.7% to close at $35.85. Standard General, Bally's largest shareholder, submitted proposal to acquire all of the outstanding shares of Bally's common stock not currently owned by the company at a price of $38 per share.
  • Capricor Therapeutics, Inc. CAPR gained 21.6% to close at $20.28. Capricor Therapeutics said it has entered into a partnership with Japanese pharma company Nippon Shinyaku for the exclusive commercialization and distribution in the U.S. of Capricor's lead asset, CAP-1002, for the treatment of Duchenne muscular dystrophy.
  • Urban One, Inc. UONE gained 21% to settle at $5.07.
  • China SXT Pharmaceuticals, Inc. SXTC jumped 20.6% to close at $0.2123. China SXT Pharmaceuticals recently priced a $3.5 million underwritten public offering of ordinary shares.
  • Nine Energy Service, Inc. NINE gained 20.5% to close at $1.35.
  • Silence Therapeutics plc SLN jumped 20.3% to settle at $21.89.
  • Progenity, Inc. PROG gained 20.3% to close at $1.54. Progenity recently announced acceptance of two abstracts on treatment of gastrointestinal disorders at ECCO'22.
  • Digital Brands Group, Inc. DBGI rose 18.4% to close at $1.5150. Digital Brands Group recently announced a definitive agreement to acquire Sundry.

Check out these penny stocks insiders are buying

  • ToughBuilt Industries, Inc. TBLT rose 17.6% to close at $0.2863.
  • Virgin Orbit Holdings, Inc. VORB climbed 17.5% to close at $7.99 after dropping 18% on Monday.
  • Dermata Therapeutics, Inc. DRMA surged 17.1% to close at $1.99.
  • Allscripts Healthcare Solutions, Inc. MDRX rose 16% to close at $20.28. Allscripts Healthcare Solutions expects Q4 revenue of $390 million - $395 million, better than the consensus of $$386.75 million. SVB Leerink upgraded Allscripts Healthcare from Market Perform to Outperform and raised the price target from $19 to $22.
  • Turquoise Hill Resources Ltd. TRQ shares gained 15.9% to close at $17.50. Rio Tinto Plc and the Mongolian government said reached an agreement to end a dispute over the Oyu Tolgoi copper-gold mining project. As part of the agreement, Turquoise Hill Resources will waive debt worth $2.4 billion owed to it by Mongolia.
  • Vivos Therapeutics, Inc. VVOS jumped 15.6% to close at $2.81. Vivos Therapeutics recently announced significant increases across several key metrics for its SleepImage Home Sleep Apnea Tests.
  • Checkpoint Therapeutics, Inc. CKPT rose 12.3% to close at $2.46 after reporting topline results from registration-enabling trial of cosibelimab in metastatic cutaneous squamous cell carcinoma. HC Wainwright & Co. maintained Checkpoint Therapeutics with a Buy and raised the price target from $17 to $26.
  • Amarin Corporation plc AMRN gained 9% to close at $3.26.
  • Telefonaktiebolaget LM Ericsson ERIC rose 7.3% to close at $11.70 after reporting upbeat core earnings for its fourth quarter.
  • Sonder Holdings Inc. SOND rose 7.1% to close at $7.66. JMP Securities, on Monday, initiated coverage on Sonder Holdings with a Market Outperform rating and announced a price target of $12.
  • Vertical Aerospace Ltd. EVTL gained 6.5% to close at $8.01.

 


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big stocks insiders are selling

Losers

  • Integrated Media Technology Limited IMTE shares dropped 21.8% to close at $8.29 on Tuesday. Integrated Media Technology recently announced the completion of the development of its online digital assets trading platform "Ouction."
  • Aerojet Rocketdyne Holdings, Inc. AJRD dipped 18.6% to close at $36.65 on Tuesday. Aerojet Rocketdyne on Lockheed Transaction said, 'We believe it is highly likely that the FTC will vote to sue to block the transaction and expect they will make a decision before Jan. 27, 2022.'
  • GlucoTrack, Inc. IGAP dropped 17.3% to close at $3.29.
  • Equitrans Midstream Corporation ETRN fell 17.3% to settle at $8.59.
  • Yoshitsu Co., Ltd TKLF fell 16.4% to close at $3.92.
  • Matinas BioPharma Holdings, Inc. MTNB declined 16.2% to close at $0.67.
  • AgileThought, Inc. AGIL dropped 15.9% to close at $4.27. AgileThought recently named Kevin Johnston as COO.
  • Gelesis Holdings, Inc. GLS declined 15.6% to settle at $5.59.
  • Pintec Technology Holdings Limited PT fell 14.9% to close at $0.56 after dipping more than 52% on Monday.
  • Gracell Biotechnologies Inc. GRCL declined 14.3% to settle at $3.72.
  • Impac Mortgage Holdings, Inc. IMH dropped 14.2% to close at $0.8411.
  • 89bio, Inc. ETNB dipped 13.6% to close at $8.29. 89bio announced topline results from a cohort of 20 patients (Cohort 7) in the Phase 1b/2a proof-of-concept study evaluating pegozafermin (formerly BIO89-100) for nonalcoholic steatohepatitis (NASH).
  • Accelerate Diagnostics, Inc. AXDX dropped 12.4% to close at $3.46. Accelerate Diagnostics Director Jack Schuler recently acquired a total of 41,912 shares at an average price of $3.94.
  • Instil Bio, Inc. TIL fell 11.5% to close at $11.87.
  • Kidpik Corp. PIK fell 11.1% to close at $6.31.
  • NeuroBo Pharmaceuticals, Inc. NRBO fell 11.1% to close at $1.04 after gaining around 5% on Monday.
  • Jianpu Technology Inc. JT dropped 10.7% to close at $0.9107.
  • HashiCorp, Inc. HCP fell 10.6% to close at $55.51.
  • Vertex Energy, Inc. VTNR fell 9.7% to close at $3.81. Clean Harbors and Vertex Energy mutually agreed to terminate planned acquisition of Vertex’s used motor oil collection and re-refining assets.
  • AMTD International Inc. HKIB fell 7% to close at $4.00 after dropping over 15% on Monday.
  • IGM Biosciences, Inc. IGMS fell 6.7% to settle at $18.56.
  • General Electric Company GE fell 6% to close at $91.11 after the company reported worse-than-expected Q4 sales results.
  • Shopify Inc. SHOP fell around 5% to close at $892.39 after Keybanc lowered its price target on the stock from $1750 to $1250.
  • Xerox Holdings Corporation XRX fell 4.8% to close at $19.98. Xerox reported a fourth-quarter FY21 sales decline of 7.9% year-on-year, to $1.78 billion, missing the consensus of $1.82 billion.

 

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasMovers From YesterdayTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...